XML 30 R28.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL AND STOCK OPTIONS (Tables)

12 Months Ended

Jun. 30, 2012

Stockholders Equity Note [Line Items]

	Year ended June 30, 2012
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		2,200,616		$	3.84
Options exercised		(19,800	)		0.66
Options forfeited		(98,644	)		3.95
Options outstanding at end of the period		2,082,172		$	3.87		4.87	$	928
Options exercisable at the end of the period		2,082,172		$	3.87		4.87	$	928
Options vested		2,082,172		$	3.87		4.87	$	928

Schedule of Options and Warrants

Warrants / Options	Exercise Price per Share		Options and Warrants for Common Stock		Options and Warrants Exercisable		Weighted Average Remaining Contractual Terms(in years)
Warrants:	$	1.00		2,002,245		2,002,245		1.41
	$	1.20		6,250		6,250		0.30
	$	1.25 - 1.28		687,072		687,072		0.51
	$	1.40 - $ 1.50		1,768,040		1,768,040		2.33
	$	1.60		181,221		181,221		2.78
	$	1.80 - $ 1.91		3,538,240		3,538,240		2.00
	$	2.50		12,900		12,900		0.47
	$	4.20		5,060,000		5,060,000		4.09
	$	5.00		495,000		495,000		0.43
Total warrants				13,750,968		13,750,968

Options:	$	0.00		110,000		95,000		7.51
	$	0.62		471,612		471,612		6.02
	$	1.04-$ 1.45		86,956		86,956		3.67
	$	2.97		20,000		20,000		5.86
	$	3.50		920,000		920,000		4.49
	$	3.72 - $ 3.80		31,550		31,550		4.44
	$	4.00		42,500		42,500		4.30
	$	4.38 - $ 4.40		456,804		456,804		4.93
	$	6.80		36,250		36,250		5.37
	$	8.20		40,000		40,000		3.63
	$	20.00		142,500		142,500		3.98
Total options				2,358,172		2,343,172

Total warrants and options				16,109,140		16,094,140

Schedule of Unvested Restricted Stock Units, Consultants

	Number
Unvested at the beginning of period		149,998
Granted		53,433
Vested		(137,431	)
Unvested at the end of the period		66,000
Expected to vest after June 30, 2012		66,000

Schedule of Unvested Restricted Stock Units

	Number
Unvested at the beginning of period		2,138,955
Granted		1,861,638
Forfeited		(146,517	)
Vested		(1,768,800	)
Unvested at the end of the period		2,085,276
Expected to vest after June 30, 2012		2,043,133

Schedule of Options and Warrants, Consultants

	Year ended June 30, 2012
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options and warrants outstanding at beginning of period		425,000		$	3.65
Options and warrants granted		12,000			0
Options and warrants exercised		(55,000	)		1.37
Options and warrants outstanding at end of the period		382,000		$	3.86		4.59	$	396

Options and warrants exercisable at the end of the period		367,000		$	4.02		4.40	$	360

Options and warrants vested		382,000		$	3.86		4.59	$	396

Options and Warrants [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

	Year ended June 30,
	2012		2011		2010
Research and development expenses	$	19	$	32	$	90
General and administrative expenses		37		73		71
	$	56	$	105	$	161

Plans [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

	Year ended June 30,
	2012		2011		2010
Research and development expenses	$	-	$	2	$	73
General and administrative expenses		-		2		138
	$	-	$	4	$	211

Restricted Stock and Restricted Stock Units [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

	Year ended June 30,
	2012		2011		2010
Research and development expenses	$	1,163	$	1,027	$	582
General and administrative expenses		3,487		1,717		775
	$	4,650	$	2,744	$	1,357

Consultant Restricted Stock Units And Restricted Stock [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

	Year ended June 30,
	2012		2011		2010
Research and development expenses	$	201	$	294	$	40
General and administrative expenses		20		178		50
	$	221	$	472	$	90

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References+ Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details